IDA blend vs Spain: Access to anti-retroviral drugs, male
IDA blend
74.0%
in 2024
Spain
91.0%
in 2022
IDA blend rank
14th
Spain rank
12th
Access to anti-retroviral drugs, male over time
- IDA blend
- Spain
How they compare
Spain currently reports 91.0% against 74.0% in IDA blend, a difference of 17.0%.
That makes Spain's figure about 1.2 times IDA blend's.
Across all 23 years both countries report, Spain has been ahead every year.
IDA blend ranks 14th and Spain ranks 12th of 19 groups.
Spain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA blend | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.5% | 41.7% | 36.2% | Spain |
| 2010s | 38.5% | 73.4% | 34.9% | Spain |
| 2020s | 64.6% | 88.7% | 24.1% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, IDA blend or Spain?
- Spain, at 91.0% against 74.0% in IDA blend as of 2022.
- What is the difference in access to anti-retroviral drugs, male between IDA blend and Spain?
- 17.0%, with Spain ahead.
- How many years of comparable data are there for IDA blend and Spain?
- 23 years are reported by both, from 2000 to 2022.
- How do IDA blend and Spain rank globally for access to anti-retroviral drugs, male?
- IDA blend ranks 14th and Spain ranks 12th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.